T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CA
201
DELISTED
CA, Inc.
CA
| $517M | 0.11% |
18,921,525
+497,271
| +3% | +$14.2M |
|
|
AGN.PRA
202
DELISTED
Allergan plc
AGN.PRA
| $513M | 0.11% |
552,870
+4,045
| +0.7% | +$4.22M |
|
203
Microchip Technology
MCHP
$43.3B
| $512M | 0.11% |
23,782,924
+6,470,580
| +37% | +$139M |
|
204
Ecolab
ECL
$77.2B
| $511M | 0.11% |
4,655,488
-1,178,737
| -20% | -$132M |
|
205
Coca-Cola
KO
$376B
| $510M | 0.11% |
12,704,771
+450,942
| +4% | +$18.1M |
|
206
Gartner
IT
$11.1B
| $509M | 0.11% |
6,065,744
+5,150
| +0.1% | +$449K |
|
207
Dentsply Sirona
XRAY
$2.26B
| $508M | 0.11% |
10,040,108
+100,715
| +1% | +$5.36M |
|
208
Acuity Brands
AYI
$10.8B
| $505M | 0.11% |
2,878,515
-595,155
| -17% | -$116M |
|
209
Archer Daniels Midland
ADM
$38.8B
| $498M | 0.11% |
12,017,780
-943,642
| -7% | -$43.1M |
|
|
WP
210
DELISTED
Worldpay, Inc.
WP
| $496M | 0.11% |
11,033,330
-1,328,148
| -11% | -$57.3M |
|
|
CVC
211
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $491M | 0.11% |
15,107,995
-3,180,662
| -17% | -$86.6M |
|
|
K
212
DELISTED
Kellanova
K
| $489M | 0.11% |
7,825,422
+1,802,758
| +30% | +$112M |
|
|
TFCFA
213
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $487M | 0.11% |
18,057,785
+7,574,468
| +72% | +$226M |
|
214
Verisk Analytics
VRSK
$23.4B
| $482M | 0.11% |
6,523,595
-270,496
| -4% | -$20.2M |
|
215
Iron Mountain
IRM
$37.4B
| $482M | 0.11% |
15,531,173
+2,541,769
| +20% | +$75.8M |
|
216
Edison International
EIX
$27B
| $480M | 0.11% |
7,609,694
+6,094,176
| +402% | +$362M |
|
|
TWX
217
DELISTED
Time Warner Inc
TWX
| $477M | 0.11% |
6,934,357
-6,707,400
| -49% | -$527M |
|
218
Factset
FDS
$9.87B
| $474M | 0.11% |
2,962,960
-340,800
| -10% | -$55.8M |
|
219
News Corp Class A
NWSA
$15.6B
| $473M | 0.11% |
37,510,326
+3,021,100
| +9% | +$42M |
|
|
CB
220
DELISTED
CHUBB CORPORATION
CB
| $468M | 0.1% |
3,812,014
+841,873
| +28% | +$103M |
|
|
SNDK
221
DELISTED
SANDISK CORP
SNDK
| $462M | 0.1% |
8,499,015
+4,241,505
| +100% | +$234M |
|
222
Macerich
MAC
$7B
| $459M | 0.1% |
5,969,777
+622,573
| +12% | +$48.2M |
|
|
FEIC
223
DELISTED
FEI COMPANY
FEIC
| $456M | 0.1% |
6,237,272
+20,219
| +0.3% | +$1.59M |
|
224
Bruker
BRKR
$8.85B
| $450M | 0.1% |
27,415,945
+12,225
| +0% | +$238K |
|
225
RTX Corp
RTX
$297B
| $449M | 0.1% |
8,012,175
-10,713,664
| -57% | -$660M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.